SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Cantor Fitzgerald Maintains Overweight on GW Pharmaceuticals, Raises Price Target to $154

Cantor Fitzgerald maintains GW Pharmaceuticals (NASDAQ:GWPH) with a Overweight and raises the price target from $120 to $154.

Benzinga · 05/14/2020 10:40

Cantor Fitzgerald maintains GW Pharmaceuticals (NASDAQ:GWPH) with a Overweight and raises the price target from $120 to $154.